Abeona Therapeutics (ABEO) Research & Development (2011 - 2026)
Abeona Therapeutics (ABEO) posted Research & Development of $5.02 million for Q2 2026, down 15.5% from $5.94 million a year earlier and down 47.5% from the prior quarter.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Research & Development (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Abeona Therapeutics was $25.5 million, down 24.6% year-over-year; for FY2025, it came in at $26.81 million, down 22.0% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- In prior years, Abeona Therapeutics' Research & Development was $34.36 million in FY2024 (+10.5%), $31.09 million in FY2023 (+7.3%), $28.97 million in FY2022 (-25.2%) and $38.73 million in FY2021 (+28.5%).
- Quarterly Research & Development has run from a low of $4.22 million in Q3 2025 to a high of $12.8 million in Q4 2021 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last five quarters, with an average decline of 6.0% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 38.5%; the weakest was Q3 2025, with a decline of 52.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $9.56 million (Q1 2026), $6.71 million (Q4 2025) and $4.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Abeona Therapeutics | 251.30 Mn | -462.66 Mn | 7.20 Mn | 5.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.02 Mn |
| Mar 31, 2026 | 9.56 Mn |
| Dec 31, 2025 | 6.71 Mn |
| Sep 30, 2025 | 4.22 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 9.94 Mn |
| Dec 31, 2024 | 8.99 Mn |
| Sep 30, 2024 | 8.94 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Mar 31, 2024 | 7.21 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Jun 30, 2023 | 8.52 Mn |
| Mar 31, 2023 | 8.04 Mn |
| Dec 31, 2022 | 6.27 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 10.55 Mn |
| Dec 31, 2021 | 12.80 Mn |
| Sep 30, 2021 | 9.06 Mn |
API Access
Abeona Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();